Scarica l'app Stockscreener
81.19
1.08%
-1.045
Tempus Ai Inc Borsa (TEM) Ultime notizie
Leica biosystems integrates tempus AI into aperio AI store - news-medical.net
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock - MarketBeat
RXRX Stock Rises As Tempus AI Deal Resets Growth Story - StocksToTrade
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know - TradingKey
Tempus AI (NASDAQ:TEM) Trading 6.1% HigherTime to Buy? - MarketBeat
Tempus AI Soars As Wall Street Bets On Data - TipRanks
Promising Artificial Intelligence Stocks To ConsiderSeptember 24th - MarketBeat
Tempus AI Chief Accounting Officer Sells $529,650 of Stock - The Globe and Mail
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4 - finance.yahoo.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics - Investing.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics By Investing.com - Investing.com UK
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test - Insider Monkey
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating - MarketBeat
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM) - Seeking Alpha
Goldman Sachs initiates coverage of Tempus AI (TEM.US) with a Neutral rating: Diagnostic business to benefit from reimbursement tailwinds, while data contracts enter a "validation phase" - Moomoo
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM) - Seeking Alpha
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion - MarketBeat
Tempus AI Fails to Trim Guardant Lawsuit Over Diagnostic Tests - Bloomberg Law News
A data partnership shifts from potential $84 million in two-year fees to $42 million in committed payments over three - Stock Titan
Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model - marketscreener.com
Tempus AI, Recursion Extend Data License, Amend Fee Structure - Moomoo
Tempus extends Recursion data partnership through 2029 By Investing.com - Investing.com Nigeria
Tempus AI: Market Is Hyping On An Uncertain Number (NASDAQ:TEM) - Seeking Alpha
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model - Business Wire
Goldman Sachs initiates Tempus AI stock coverage with neutral rating By Investing.com - Investing.com Australia
Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target - Moomoo
Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Complex Terrain of Healthcare Innovation - DirectorsTalk Interviews
Tempus AI (TEM) Is Building a Heart Failure Agent That Never Sleeps - finance.yahoo.com
Tempus AI (TEM), What Is Behind The Latest Buzz? - finance.yahoo.com
What Is Tempus AI (TEM)? The $98.5M Mark Behind Q2 - Phemex
Tempus AI CEO Eric P. Lefkofsky sells $16.1 million of stock - Investing.com Nigeria
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative - finance.yahoo.com
Tempus AI EVP, Chief Legal Officer Andrew Polovin disposes of 2,951 common shares for $221,325 - Bitget
Tempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million Genomes - finance.yahoo.com
Tempus AI’s EVP, chief legal officer, sells $221,325 in stock By Investing.com - Investing.com Canada
Tempus AI (TEM) Chief Accounting Officer Ryan Bartolucci Sells 7 - GuruFocus
Andrew Polovin Sells 2,951 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 200,000 Shares - MarketBeat
Tempus AI chief accounting officer sells $529,650 in stock By Investing.com - Investing.com Nigeria
Tempus AI chief accounting officer sells $529,650 in stock - Investing.com
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock By Investing.com - Investing.com South Africa
Tempus AI(TEM.US) 10% Shareholder Sells US$16.11 Million in Common Stock - Moomoo
Tempus AI (TEM) data chief’s spouse sells 700 shares under plan - Stock Titan
EVP at Tempus AI (TEM) sells shares in preset plan trade - Stock Titan
Tempus AI Pulls Back After 40% Rally as Analysts Question Valuation - finance.biggo.com
Tempus AI outlook: revenue growth and risks in focus By Investing.com - Investing.com Nigeria
Tempus AI outlook: revenue growth and risks in focus - Investing.com
Why Is Tempus AI Stock Falling Friday? - Benzinga
Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength? - finance.yahoo.com
Tempus AI Stock: 5 Straight Green Days, Up 37% - Trefis
Day 6Market View: Rates, Oil, & Tempus AI - Moomoo
Form 144 | Tempus AI(TEM.US) Officer Proposes to Sell 13.99 Million in Common Stocks - Moomoo
Tempus AI Options Spot-On: On September 17th, 122K Contracts Were Traded, With 415.18K Open Interest - Moomoo
Tempus AI (NASDAQ:TEM): What's Fueling Its Volume Surge? - kalkinemedia.com
Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak - Barron's
Enterprise value to EBITDA forward of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEMC - TradingView
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeHere's Why - MarketBeat
Tempus AI (TEM) Extends Rally After Earnings Beat And $1.5B Deal - StocksToTrade
TEM Stock Jumps As Tempus AI Joins Profitable AI Health Elite - timothysykes.com
Tempus AI Sees Unusually Large Options Volume (NASDAQ:TEM) - MarketBeat
0.46%
1.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):